Allianz Asset Management
VIVO

Allianz Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Allianz Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,384
Closed -$498K – 2201
2022
Q2 		$498K Sell
16,384
-15,932
-49% -$431K ﹤0.01% 1893
2022
Q1 		$839K Sell
32,316
-31,549
-49% -$750K ﹤0.01% 1935
2021
Q4 		$1.3M Sell
63,865
-240,532
-79% -$4.61M ﹤0.01% 1787
2021
Q3 		$5.86M Buy
304,397
+5,811
+2% +$116K ﹤0.01% 1219
2021
Q2 		$6.62M Buy
298,586
+32,398
+12% +$687K 0.01% 994
2021
Q1 		$6.99M Buy
266,188
+230,088
+637% +$5.47M 0.01% 949
2020
Q4 		$675K Sell
36,100
-11,186
-24% -$209K ﹤0.01% 1572
2020
Q3 		$803K Sell
47,286
-39,536
-46% -$768K ﹤0.01% 1491
2020
Q2 		$2.02M Buy
+86,822
New +$1.26M ﹤0.01% 1602
2016
Q4 		– Sell
-10,065
Closed -$194K – 2700
2016
Q3 		$194K Hold
10,065
– – ﹤0.01% 2523
2016
Q2 		$196K Sell
10,065
-3,730
-27% -$73.1K ﹤0.01% 2509
2016
Q1 		$284K Buy
+13,795
New +$272K ﹤0.01% 2377

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allianz Asset Management's VIVO Position: Q3 2022 in Review

Allianz Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 16,384 shares — an estimated $498K sold.

Allianz Asset Management first reported a position in VIVO in Q1 2016 and held it in 12 quarters. The position peaked at $6.99M in Q1 2021. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • Allianz Asset Management reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • Allianz Asset Management sold 16,384 Meridian Bioscience Inc shares in Q3 2022, an estimated $498K.
  • Allianz Asset Management first reported a position in Meridian Bioscience Inc in Q1 2016 and held it in 12 quarters.
  • Allianz Asset Management's Meridian Bioscience Inc position peaked at $6.99M in Q1 2021.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on Allianz Asset Management's 13F filing for Q3 2022, filed 8 Nov 2022.